1. 1203 Blockade of the mechanistic target of rapamycin elicits rapid and lasting improvement of disease activity through restraining pro-inflammatory T cell lineage specification in patients with active SLE. (14th December 2022) Authors: Lai, Zhi-Wei; Kelly, Ryan; Winans, Thomas; Marchena, Ivan; Shadakshari, Ashwini; Yu, Julie; Dawood, Maha; Garcia, Ricardo; Tily, Hajra; Francis, Lisa; Faraone, Stephen V; Phillips, Paul E; Perl, Andras Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 3 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. Issue 4 (April 2020) Authors: Kollins, Scott H; DeLoss, Denton J; Cañadas, Elena; Lutz, Jacqueline; Findling, Robert L; Keefe, Richard S E; Epstein, Jeffery N; Cutler, Andrew J; Faraone, Stephen V Journal: Lancet Issue: Volume 2:Issue 4(2020) Page Start: e168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ADHD : non-pharmacologic interventions /: non-pharmacologic interventions. (2014) Editors: Faraone, Stephen V; Antshel, Kevin M Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adult attention-deficit hyperactivity disorder: key conceptual issues. (June 2016) Authors: Asherson, Philip; Buitelaar, Jan; Faraone, Stephen V; Rohde, Luis A Journal: Lancet Issue: Volume 3:Number 6(2016) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An innovative SMS intervention to improve adherence to stimulants in children with ADHD: Preliminary findings. (August 2020) Authors: Fried, Ronna; DiSalvo, Maura; Kelberman, Caroline; Adler, Amos; McCafferty, Debra; Woodworth, K Yvonne; Green, Allison; Biederman, Itai; Faraone, Stephen V; Biederman, Joseph Journal: Journal of psychopharmacology Issue: Volume 34:Number 8(2020) Page Start: 883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study. (September 2018) Authors: Cortese, Samuele; Sun, Shihua; Zhang, Junhua; Sharma, Esha; Chang, Zheng; Kuja-Halkola, Ralf; Almqvist, Catarina; Larsson, Henrik; Faraone, Stephen V Journal: Lancet Issue: Volume 5:Number 9(2018) Page Start: 717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Attention deficit hyperactivity disorder and premature death. Issue 9983 (30th May 2015) Authors: Faraone, Stephen V Journal: Lancet Issue: Volume 385:Issue 9983(2015) Page Start: 2132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Background, clinical features and treatment of attention deficit hyperactivity disorder in children. (October 2013) Authors: Warikoo, Nisha; Faraone, Stephen V Journal: Expert opinion on pharmacotherapy Issue: Volume 14:Number 14(2013) Page Start: 1885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BD-02 Blockade of the mechanistic target of rapamycin elicits rapid and lasting improvement of disease activity through restraining pro-inflammatory T cell lineage specification in patients with active SLE. (August 2018) Authors: Lai, Zhi-Wei; Kelly, Ryan; Winans, Thomas; Marchena, Ivan; Shadakshari, Ashwini; Yu, Julie; Dawood, Maha; Garcia, Ricardo; Tily, Hajra; Francis, Lisa; Faraone, Stephen V; Phillips, Paul E; Perl, Andras Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 2 Page Start: A13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole. (May 2022) Authors: Wozniak, Janet; DiSalvo, Maura; Farrell, Abigail; Yule, Amy; Joshi, Gagan; Cook, Emmaline; Faraone, Stephen V; Biederman, Joseph Journal: Journal of psychopharmacology Issue: Volume 36:Number 5(2022) Page Start: 637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗